Article

Expression of a Dianthus flavonoid glucosyltransferase in Saccharomyces cerevisiae for whole-cell biocatalysis

School of Chemical Engineering, Purdue University, West Lafayette, IN 47907, USA.
Journal of Biotechnology (Impact Factor: 2.88). 07/2009; 142(3-4):233-41. DOI: 10.1016/j.jbiotec.2009.05.008
Source: PubMed

ABSTRACT Glycosyltransferases are promising biocatalysts for the synthesis of small molecule glycosides. In this study, Saccharomyces cerevisiae expressing a flavonoid glucosyltransferase (GT) from Dianthus caryophyllus (carnation) was investigated as a whole-cell biocatalyst. Two yeast expression systems were compared using the flavonoid naringenin as a model substrate. Under in vitro conditions, naringenin-7-O-glucoside was formed and a higher specific glucosyl transfer activity was found using a galactose inducible expression system compared to a constitutive expression system. However, S. cerevisiae expressing the GT constitutively was significantly more productive than the galactose inducible system under in vivo conditions. Interestingly, the glycosides were recovered directly from the culture broth and did not accumulate intracellularly. A previously uncharacterized naringenin glycoside formed using the D. caryophyllus GT was identified as naringenin-4'-O-glucoside. It was found that S. cerevisiae cells hydrolyze naringenin-7-O-glucoside during whole-cell biocatalysis, resulting in a low final glycoside titer. When phloretin was added as a substrate to the yeast strain expressing the GT constitutively, the natural product phlorizin was formed. This study demonstrates S. cerevisiae is a promising whole-cell biocatalyst host for the production of valuable glycosides.

1 Follower
 · 
103 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Glycosylation is one of the powerful strategies to diversify natural products. The modification of natural products by glycosylation alters the pharmacological properties of the parent compounds. The production of glyco-conjugated novel compounds by in vivo glycosylation is highly feasible and applicable in industrial level in comparison to in vitro methods. Generating microbial cell factories and direct use of such cells as enzyme bags to produce desire products by applying this approach is highly economical and easily adoptable for facile production of small molecule glycosides. Nonetheless, this tool may lead to generate novel compounds with improved physical and biological properties for development of future drugs. Here, we have successfully set up to scale up the in vivo glycosylation in 5 L fermentation culture by using 7 L fermenter vessel for flavonoid glycosides production. The in vivo glycosylation approach in fermenter might result in enhanced bioconversion of the compound rather than in small scale flask culture. The methodology has been explained in detail.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Glycosylation is one of the powerful strategies to diversify natural products. The modification of natural products by glycosylation alters the pharmacological properties of the parent compounds. The production of glyco-conjugated novel compounds by in vivo glycosylation is highly feasible and applicable in industrial level in comparison to in vitro methods. Generating microbial cell factories and direct use of such cells as enzyme bags to produce desire products by applying this approach is highly economical and easily adoptable for facile production of small molecule glycosides. Nonetheless, this tool may lead to generate novel compounds with improved physical and biological properties for development of future drugs. Here, we have successfully set up to scale up the in vivo glycosylation in 5 L fermentation culture by using 7 L fermenter vessel for flavonoid glycosides production. The in vivo glycosylation approach in fermenter might result in enhanced bioconversion of the compound rather than in small scale flask culture. The methodology has been explained in detail.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Glycosylation is one of the powerful strategies to diversify natural products. The modification of natural products by glycosylation alters the pharmacological properties of the parent compounds. The production of glyco-conjugated novel compounds by in vivo glycosylation is highly feasible and applicable in industrial level in comparison to in vitro methods. Generating microbial cell factories and direct use of such cells as enzyme bags to produce desire products by applying this approach is highly economical and easily adoptable for facile production of small molecule glycosides. Nonetheless, this tool may lead to generate novel compounds with improved physical and biological properties for development of future drugs. Here, we have successfully set up to scale up the in vivo glycosylation in 5 L fermentation culture by using 7 L fermenter vessel for flavonoid glycosides production. The in vivo glycosylation approach in fermenter might result in enhanced bioconversion of the compound rather than in small scale flask culture. The methodology has been explained in detail.